Drug copayments matter

I want to quickly note that on this blog we’ve covered the effect of drug copayments on patients’ adherence to drug regimens:

It’s the last point that leads naturally to the consideration of value-based insurance design. It’s completely reasonable to consider such an approach for childhood asthma (for which cost-sharing is a documented issue), as well as other medications and therapies.
Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below

Subscribe

* indicates required
Email Format